Event details

• Date: 20 February 2024
• Time: 09:00 am to 15:00 pm CET
• Location: Hotel Renaissance – Rue du Parnasse 19, 1050 Brussels, Belgium
• Registration will start at 8:30 am CET

Herbal medicinal products play a crucial role in patient treatment throughout Europe, adhering to the same regulatory standards as chemical medicinal products. These products are commonly available over the counter in pharmacies, serving as easily accessible and integral components of self-care for mild infections and ailments. Despite their significance, herbal medicinal products face unique hurdles, including competition with botanical-containing food supplements and distinct bureaucratic challenges.

Recent policy developments, such as the ongoing revision of the General Pharmaceutical Legislation and the European Parliament’s Subcommittee on Public Health (SANT) implementation report on the Health Claims Regulation, have brought these challenges to the forefront. Therefore, this summit serves as a platform for engaging discussions with key stakeholders. The goal is to collaboratively discuss the current challenges and opportunities for herbal medicinal products in the context of numerous European legislative initiatives, and to work towards enhancing the situation for these products.

Together with:

• Prof. Dr. Susanne Alban, University of Kiel
• Christelle Anquez-Traxler, Regulatory and Scientific Affairs Manager, AESGP
• Andreas Glück, Member of the European Parliament
• Thomas Heil, Vice President, IQVIA Consumer Health
• Prof. Dr. Michael Heinrich, President GA
• Dr. Peter Liese, Member of the European Parliament
• Manfred Lucha, Minister of Social Affairs, Health and Integration of Baden-Württemberg
• Angela Müller, Head of Global Regulatory Affairs, Dr. Willmar Schwabe
• Dr. Bernd Roether, Head Division Drug Regulatory Affairs, Bionorica SE
• Dr. Nico Symma, Manager Herbal and Complementary Medicinal Products, German Medicines Manufacturers‘ Association
• Dr. Emiel van Galen, Chair Herbal Medicinal Product Committee, European Medicines Agency
• Dr. Jacqueline Wiesner, Head of the Department of Herbal and Traditional Medicines, BfArM

We will be delving into the following topics:

• Future and relevance of herbal medicinal products in the EU – outlook and challenges from Competent Authority perspective
• Revision of the EU pharmaceutical legislation – Impact on herbal medicinal products
• Quo vadis “Health Claims Regulation” – Implementation report of the European Parliament
• Regulatory challenges of herbal medicinal products

For further information, please find attached the draft programme of the Summit.

Secure your place by registering for free through this link.